RS
BLTE

R Squared’s Belite Bio BLTE Stock Holding History

R Squared’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Buy
+1,338
New +$205K 0.11% 337

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

R Squared's BLTE Position: Q2 2026 in Review

R Squared opened a new position in Belite Bio (BLTE) in Q2 2026: 1,338 shares worth $206K. The stake represents 0.11% of the portfolio and ranks #337 among its holdings.

81 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • R Squared held 1,338 shares of Belite Bio worth $206K as of Q2 2026.
  • Belite Bio was a new R Squared position in Q2 2026.
  • Belite Bio made up 0.11% of R Squared's portfolio in Q2 2026, its #337 holding.
  • 81 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.